26Serious

Charlie Adam

Ask VT AI

View News Summary

Coca-Cola's Q1 revenue falls, but shares rise on strong outlook and growth in emerging markets.
Novo Nordisk expands access to weight-loss drug Wegovy through partnerships with telehealth companies, offering discounted rates to address the FDA crackdown on compounded GLP-1 drugs.
FBI's crackdown on media leaks through polygraph tests creates a toxic agency climate, raising concerns over civil liberties and national security.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Coca-Cola's Q1 revenue falls, but shares rise on strong outlook and growth in emerging markets.
Novo Nordisk expands access to weight-loss drug Wegovy through partnerships with telehealth companies, offering discounted rates to address the FDA crackdown on compounded GLP-1 drugs.
FBI's crackdown on media leaks through polygraph tests creates a toxic agency climate, raising concerns over civil liberties and national security.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Charlie Adam